Louisiana moves to back psychedelic drug research for mental health, addiction treatment

The Louisiana Legislature is on the verge of approving state support for clinical studies on psychedelic drugs used to treat mental health and substance abuse disorders. Senate Bill 43, sponsored by Sen. Patrick McMath, R-Mandeville, would create a state health initiative for studies on ibogaine, psilocybin, MDMA (also known as “Molly”) and other psychedelic drugs […]

Original Source

Read the full article at Lailluminator →

KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.